Jean-Luc Georges Laurent Battini

Title: Innovations of Jean-Luc Georges Laurent Battini

Introduction

Jean-Luc Georges Laurent Battini is a notable inventor based in Montpellier, France. He has made significant contributions to the field of medical research, particularly in the area of cancer diagnosis and treatment. With a total of 2 patents, his work has the potential to impact the medical community significantly.

Latest Patents

Battini's latest patents include "GLUT-1 as a receptor for HTLV envelopes and its uses." This invention relates to the use of the ubiquitous vertebrate glucose transporter GLUT1, or fragments or sequences derived thereof, for the in vitro diagnosis of cancers when used as a tumor marker. It also focuses on the screening of compounds useful for the preparation of drugs aimed at preventing or treating pathologies linked to an infection of an individual with a PTLV. Furthermore, it addresses pathologies linked to an overexpression of GLUT1 on cell surfaces and the in vitro detection of GLUT1 on cell surfaces. The invention also encompasses pharmaceutical compositions containing GLUT1 and their uses in the prevention or treatment of related pathologies.

Career Highlights

Throughout his career, Battini has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université de Montpellier. His research has been pivotal in advancing our understanding of GLUT1 and its applications in medical science.

Collaborations

Battini has collaborated with notable colleagues, including Nicolas Gabriel Albert Manel and Felix Jinhyun Kim. These collaborations have further enriched his research and contributed to the development of innovative solutions in his field.

Conclusion

Jean-Luc Georges Laurent Battini's work exemplifies the intersection of innovation and medical research. His patents and collaborations highlight his commitment to advancing cancer diagnosis and treatment. His contributions are likely to have a lasting impact on the medical community.